ASIA JOBS
The Premier Source for latest jobs and trends in
Pharma, healthcare & biotechnology & research
We connect millions of readers to new trends &
opportunities worldwide.
Trusted by the Business of Biotech & Health Sciences, University
Professors, Companies and Other Research Organizations
For Job Seekers For Job Employer
Search job by location Post Unlimited Jobs
Create multiple job alerts Activate & deactivate jobs
Customize job search according Candidate Search
to industry, Career type Download candidates resume
Receive industry updates
Expert’s thoughts from leaders
Please visit: https://www.biospectrumjobs.com
For more information Email us at: [email protected]
WE’RE CELEBRATING.
A NEW ANTIBODY
FAILED TO FAIL.
The US FDA has granted a Breakthrough Therapy designation to the first anti-TIGIT
therapy for use in NSCLC in combination with PD-L1 blockade. TIGIT expression in
paraffin-embedded non-small cell lung cancer is observed using TIGIT (E5Y1W) XP®
Rabbit mAb #99567.
OUR PROCESS — YOUR SUCCESS.
As a privately held company founded and led by
active research scientists, we understand your
needs as a researcher. Like you, we only want to use
products that are specific and deliver reproducible
results. We validate every one of our thousands of
antibodies and research products in-house. If any
product fails to meet our stringent standards, we
won’t sell it. But when one passes, it’s a big deal. For
over 20 years, researchers have trusted CST to help
them achieve experimental success. You can, too.
www.cellsignal.com
© 2022 Cell Signaling Technology, Inc. Cell Signaling Technology, CST, and XP are trademarks or registered trademarks of Cell Signaling Technology, Inc. 22-BCH-13880-MAR22
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Oz BUDGET BOLSTERS HEALTHCARE
Circumstances have continued to evolve as the COVID-19 Omicron variant has added further pressure to Australia’s healthcare sector, as well as increasing supply chain disruptions, bringing about staff shortages and reducing household spending. With a Federal election due on May 21, 2022 to elect members of the 47th Parliament of Australia, Josh Frydenberg, Treasurer of the Commonwealth of Australia presented the Federal Budget on March 29. The Coalition Government led by Scott Morrison is investing in a stronger health system as part of its plan for a stronger future through a record $132 billion in 2022–23 Budget, increasing to $140 billion in 2025–26, with a total commitment of $537 billion over the next four years. This record funding will ensure Australians have access to improved healthcare, when and where they need it, helping them to lead healthier lives, with improved health outcomes and to provide ongoing protection against COVID-19.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search